Home › Valeant Pharma Q3 profit beats estimates, company raises outlook for Q4, 2015
 

Keywords :   


Valeant Pharma Q3 profit beats estimates, company raises outlook for Q4, 2015

2014-10-20 16:06:43| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. beat analyst estimates for third-quarter profit and says both the fourth quarter and 2015 are looking more positive than estimates have forecast. The Montreal-area company reported US$275.4 million of net income, or 82 cents per share, under standard accounting and US$718.8 million after adjustments, resulting in $2.11 per share of adjusted EPS.

Tags: company profit estimates outlook

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »